WBA lowered its fiscal 2024 adjusted EPS guidance to $2.80 to $2.95 reflecting challenging pharmacy industry trends and a worse-than-expected U.S. consumer environment.
The AI tool merges dunnhumby’s Retailer Preference Index with Placer.ai’s geolocation data to maintain actionable knowledge about a retailer’s competitive threat.